Modern facilities & Excellent production conditions

COOPER

Our
Company

The Pharmaceutical Company COOPER S.A. was founded in 1936 and has had a continued presence in the pharmaceutical Greek pharmaceutical market up to the present day.

Today the fully Greek-owned company, established with a new equity and administrative structure in 2006, looks forward to the future with optimism, ready to face the challenges of the present.

Its aim is to establish itself as a dynamic pharmaceutical production unit, whilst developing partnerships with major companies abroad in the fields of both pharmaceutical medicine and medical devices.

MODERN
FACILITIES

MORDEN
LABS

CERTIFIED
PROCEDURES

WATER
PRODUCTION

TIMELINE

  • 1936
  • 1948
  • 1961
  • 2001
  • 2006
  • 2009
1936
It was founded by Constantine Lemos, a pharmacist who opened a pharmacy in Omonia on Panepistimiou Street (where the National Bank is today) in collaboration with Dr. Albert Salmon, founder of the French company, LA COOPERATION PHARMACEUTIQUE FRANCAISE, on the same premises (64 Aristovoulou, 11853 Petralona) it still occupies today, with an initial surface area 1.900m2
1948
Facilities were expanded by 1000 m2 for manufacture of SPECIA HELLAS LTD products and a new 750 m2 extension was devoted to the manufacture of BAXTER products (serum injections).
1961
COOPER SA acquired a majority shareholding in SPECIA HELLAS LTD which was established in the meantime between COOPER SA and SPECIA/RHONE POULENC for the production of sterile products, primarily antibiotics.
2001
In 2001 COOPER SA entered a new partnership with Fresenius Kabi Hellas SA (a subsidiary of Fresenius A.G. Germany) for contract manufacturing of large volume injectable solutions on behalf of FKH for the Greek market, as well as their distribution throughout the country.
2006
In June 2006, COOPER SA launched its new, dynamic course of development in the healthcare field. Reorganization, integration of new management and marketing methods.
2009
This year marked the expansion of the cooperation agreementwith Fresenius Kabi Hellas in the hospital sector to include distribution, promotion and sale of a range of generic injectable products (antibiotics and anesthetics).

COOPERATIONS